Anna Kiialainen
Roche (Switzerland)(CH)
Publications by Year
Research Areas
Hemophilia Treatment and Research, Tuberous Sclerosis Complex Research, Genetic Mapping and Diversity in Plants and Animals, Platelet Disorders and Treatments, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade(2018)1,154 cited
- → Genome Sequence, Comparative Analysis, and Population Genetics of the Domestic Horse(2009)841 cited
- → Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade(2017)569 cited
- → Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study(2019)376 cited
- → DAP12/TREM2 Deficiency Results in Impaired Osteoclast Differentiation and Osteoporotic Features(2003)311 cited
- → Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity(2016)257 cited
- → Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy using Human Induced Pluripotent Stem Cells(2014)240 cited
- → White-to-brown metabolic conversion of human adipocytes by JAK inhibition(2014)185 cited
- → Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients(2014)147 cited
- → DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia(2009)144 cited